267 related articles for article (PubMed ID: 27576168)
1. Preliminary evidence for association of genetic variants in pri-miR-34b/c and abnormal miR-34c expression with attention deficit and hyperactivity disorder.
Garcia-Martínez I; Sánchez-Mora C; Pagerols M; Richarte V; Corrales M; Fadeuilhe C; Cormand B; Casas M; Ramos-Quiroga JA; Ribasés M
Transl Psychiatry; 2016 Aug; 6(8):e879. PubMed ID: 27576168
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs).
Sánchez-Mora C; Ramos-Quiroga JA; Garcia-Martínez I; Fernàndez-Castillo N; Bosch R; Richarte V; Palomar G; Nogueira M; Corrales M; Daigre C; Martínez-Luna N; Grau-Lopez L; Toma C; Cormand B; Roncero C; Casas M; Ribasés M
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1463-73. PubMed ID: 23906647
[TBL] [Abstract][Full Text] [Related]
3. Preliminary comparison of plasma notch-associated microRNA-34b and -34c levels in drug naive, first episode depressed patients and healthy controls.
Sun N; Lei L; Wang Y; Yang C; Liu Z; Li X; Zhang K
J Affect Disord; 2016 Apr; 194():109-14. PubMed ID: 26807671
[TBL] [Abstract][Full Text] [Related]
4. Pri-miR-34b/c rs4938723 Polymorphism Contributes to Coronary Artery Disease Susceptibility.
Cen J; Xiong Q; Yang X; Guo J; Xiong XD; Zhang A
Arch Med Res; 2019 May; 50(4):170-174. PubMed ID: 31499476
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic signature for attention-deficit/hyperactivity disorder: identification of miR-26b-5p, miR-185-5p, and miR-191-5p as potential biomarkers in peripheral blood mononuclear cells.
Sánchez-Mora C; Soler Artigas M; Garcia-Martínez I; Pagerols M; Rovira P; Richarte V; Corrales M; Fadeuilhe C; Padilla N; de la Cruz X; Franke B; Arias-Vásquez A; Casas M; Ramos-Quiroga JA; Ribasés M
Neuropsychopharmacology; 2019 Apr; 44(5):890-897. PubMed ID: 30568281
[TBL] [Abstract][Full Text] [Related]
6. Single-nucleotide polymorphism of the pri-miR-34b/c gene is not associated with susceptibility to congenital heart disease in the Han Chinese population.
Liu YM; Wang Y; Peng W; Wu Z; Wang XH; Wang ML; Wang W; Sun J; Zhang ZD; Mo XM
Genet Mol Res; 2013 Aug; 12(3):2937-44. PubMed ID: 24065649
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
[TBL] [Abstract][Full Text] [Related]
8. Gray matter volume and microRNA levels in patients with attention-deficit/hyperactivity disorder.
Wang LJ; Li SC; Kuo HC; Chou WJ; Lee MJ; Chou MC; Tseng HH; Hsu CF; Lee SY; Lin WC
Eur Arch Psychiatry Clin Neurosci; 2020 Dec; 270(8):1037-1045. PubMed ID: 31240443
[TBL] [Abstract][Full Text] [Related]
9. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
[TBL] [Abstract][Full Text] [Related]
11. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study.
Liu P; Zhuo ZJ; Zhu J; Yang Z; Xin Y; Li S; Li L; Li Y; Wang H; He J
J Gene Med; 2020 Jul; 22(7):e3182. PubMed ID: 32166848
[TBL] [Abstract][Full Text] [Related]
12. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
[TBL] [Abstract][Full Text] [Related]
13. Association between polymorphisms in the promoter region of pri-miR-34b/c and risk of hepatocellular carcinoma.
Chen LL; Shen Y; Zhang JB; Wang S; Jiang T; Zheng MQ; Zheng ZJ; Chen CX
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808368
[TBL] [Abstract][Full Text] [Related]
14. Interactions of Pri-miRNA-34b/c and TP53 Polymorphisms on the Risk of Osteoporosis.
Jia F; Sun R; Li J; Li Q; Chen G; Fu W
Genet Test Mol Biomarkers; 2016 Jul; 20(7):398-401. PubMed ID: 27227383
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of miR-34b/c polymorphisms to the risk of ischemic stroke.
Wei G; Liao C; Jian C; Liang L; Liu J; Tang Y; Wei Y
J Hypertens; 2020 Aug; 38(8):1481-1487. PubMed ID: 32149930
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of miRNA let7a-2 and pri-mir-34b/c are associated with an increased risk of papillary thyroid carcinoma and clinical/pathological features.
Heidari Z; Mohammadpour-Gharehbagh A; Eskandari M; Harati-Sadegh M; Salimi S
J Cell Biochem; 2019 May; 120(5):8640-8647. PubMed ID: 30552691
[TBL] [Abstract][Full Text] [Related]
17. Nr3C1-Bhlhb2 Axis Dysregulation Is Involved in the Development of Attention Deficit Hyperactivity.
Wu LH; Cheng W; Yu M; He BM; Sun H; Chen Q; Dong YW; Shao XT; Cai QQ; Peng M; Wu XZ
Mol Neurobiol; 2017 Mar; 54(2):1196-1212. PubMed ID: 26820676
[TBL] [Abstract][Full Text] [Related]
18. Profiling of miRNAs in serum of children with attention-deficit hyperactivity disorder shows significant alterations.
Zadehbagheri F; Hosseini E; Bagheri-Hosseinabadi Z; Rekabdarkolaee HM; Sadeghi I
J Psychiatr Res; 2019 Feb; 109():185-192. PubMed ID: 30557705
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk.
Sanaei S; Hashemi M; Rezaei M; Hashemi SM; Bahari G; Ghavami S
Biomed Rep; 2016 Jul; 5(1):125-129. PubMed ID: 27347415
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of miR-34b and miR-34c enhances α-synuclein expression in Parkinson's disease.
Kabaria S; Choi DC; Chaudhuri AD; Mouradian MM; Junn E
FEBS Lett; 2015 Jan; 589(3):319-25. PubMed ID: 25541488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
